DOLORGIET GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.dolorgiet.de
Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Dolorgiet GmbH & Co. KG
- Target Recruit Count
- 150
- Registration Number
- NCT01757613
© Copyright 2025. All Rights Reserved by MedPath